Treatments
Cancer
Neuroendocrine Carcinoma
Neuroendocrine tumors (NETs), also known as Neuroendocrine Carcinoma, are rare tumors that develop in the cells of the neuroendocrine system.
Drugs used to treat Neuroendocrine Carcinoma
The following list of medications are in some way related to or used in the treatment of this condition:
|
Drug name |
Rating |
Reviews |
Activity |
Rx/OTC |
Pregnancy |
CSA |
Alcohol |
|
Lanreotide |
Rate |
Add review |
Rx |
C |
N |
N/A |
No interaction with alcohol |
|
Afinitor |
5.0 |
2 reviews |
Rx |
D |
N |
N/A |
No interaction with alcohol |
|
Somatuline Depot |
Rate |
Add review |
Rx |
C |
N |
N/A |
No interaction with alcohol |
|
Everolimus |
5.3 |
4 reviews |
Rx |
D |
N |
N/A |
No interaction with alcohol |
|
Lutathera |
Rate |
Add review |
Rx |
N/A |
N |
N/A |
No interaction with alcohol |
|
Zortress |
Rate |
Add review |
Rx |
D |
N |
N/A |
No interaction with alcohol |
|
Lutetium Lu 177 Dotatate |
Rate |
Add review |
Rx |
N/A |
N |
N/A |
No interaction with alcohol |
Frequently asked questions
Topics under Neuroendocrine Carcinoma:
Legend:
Rating: For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity: Activity is based on recent site visitor activity relative to other medications in the list.
Rx: Prescription only.
OTC: Over-the-counter.
Rx/OTC: Prescription or Over-the-counter.
Off-label: This medication may not be approved by the FDA for the treatment of this condition.
EUA: An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Expanded Access: Expanded Access is a potential pathway for a patient with a serious or
